Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Proteomics - Technologies, Markets and Companies


      News provided by

      Reportlinker

      Dec 29, 2011, 09:36 ET

      Share this article

      Share this article


      NEW YORK, Dec. 29, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

      Proteomics - Technologies, Markets and Companies

      http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

      Summary

      This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass spectrometry. Microanalytical protein characterization with multidimentional liquid chromatography/mass spectrometry improves the throughput and reliability of peptide mapping. Matrix-Assisted Laser Desorption Mass Spectrometry (MALDI-MS) has become a widely used method for determination of biomolecules including peptides, proteins. Functional proteomics technologies include yeast two-hybrid system for studying protein- protein interactions. Establishing a proteomics platform in the industrial setting initially requires implementation of a series of robotic systems to allow a high-throughput approach for analysis and identification of differences observed on 2D electrophoresis gels. Protein chips are also proving to be useful. Proteomic technologies are now being integrated into the drug discovery process as complimentary to genomic approaches. Toxicoproteomics, i.e. the evaluation of protein expression for understanding of toxic events, is an important application of proteomics in preclincial drug safety. Use of bioinformatics is essential for analyzing the massive amount of data generated from both genomics and proteomics.

      Proteomics is providing a better understanding of pathomechanisms of human diseases. Analysis of different levels of gene expression in healthy and diseased tissues by proteomic approaches is as important as the detection of mutations and polymorphisms at the genomic level and may be of more value in designing a rational therapy. Protein distribution / characterization in body tissues and fluids, in health as well as in disease, is the basis of the use of proteomic technologies for molecular diagnostics. Proteomics will play an important role in medicine of the future which will be personalized and will combine diagnostics with therapeutics. Important areas of application include cancer (oncoproteomics) and neurological disorders (neuroproteomics). The text is supplemented with 43 tables, 27 figures and over 500 selected references from the literature.

      The number of companies involved in proteomics has increased remarkably during the past few years. More than 300 companies have been identified to be involved in proteomics and 217 of these are profiled in the report with 480 collaborations.

      The markets for proteomic technologies are difficult to estimate as they are not distinct but overlap with those of genomics, gene expression, high throughput screening, drug discovery and molecular diagnostics. Markets for proteomic technologies are analyzed for the year 2011 and are projected to years 2016 and 2021. The largest expansion will be in bioinformatics and protein biochip technologies. Important areas of application are cancer and neurological disorders

      Table of Contents

      0. Executive Summary 15

      1. Basics of Proteomics 17

      Introduction 17

      History 17

      Nucleic acids, genes and proteins 18

      Genome 18

      DNA 19

      RNA 19

      MicroRNAs 19

      Decoding of mRNA by the ribosome 20

      Genes 21

      Alternative splicing 21

      Transcription 22

      Gene regulation 22

      Gene expression 23

      Chromatin 23

      Golgi complex 24

      Proteins 24

      Spliceosome 25

      Functions of proteins 25

      Inter-relationship of protein, mRNA and DNA 26

      Proteomics 27

      Mitochondrial proteome 28

      S-nitrosoproteins in mitochondria 28

      Proteomics and genomics 29

      Classification of proteomics 31

      Levels of functional genomics and various "omics" 31

      Glycoproteomics 32

      Transcriptomics 32

      Metabolomics 32

      Cytomics 33

      Phenomics 33

      Proteomics and systems biology 33

      Functional synthetic proteins 34

      2. Proteomic Technologies 35

      Key technologies driving proteomics 35

      Sample preparation 36

      New trends in sample preparation 36

      Pressure Cycling Technology 37

      Protein separation technologies 37

      High resolution 2D gel electrophoresis 37

      Variations of 2D gel technology 38

      Limitations of 2DGE and measures to overcome these 38

      1-D sodium dodecyl sulfate (SDS) PAGE 38

      Capillary electrophoresis systems 39

      Head column stacking capillary zone electrophoresis 39

      Removal of albumin and IgG 39

      Companies with protein separation technologies 40

      Protein detection 41

      Protein identification and characterization 42

      Mass spectrometry (MS) 42

      Companies involved in mass spectrometry 42

      Electrospray ionization 43

      Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry 44

      Cryogenic MALDI- Fourier Transform Mass Spectrometry 45

      Stable-isotope-dilution tandem mass spectrometry 46

      HUPO Gold MS Protein Standard 46

      High performance liquid chromatography 46

      Multidimensional protein identification technology (MudPIT) 47

      Peptide mass fingerprinting 47

      Combination of protein separation technologies with mass spectrometry 47

      Combining capillary electrophoresis with mass spectrometry 47

      2D PAGE and mass spectrometry 48

      Quantification of low abundance proteins 48

      SDS-PAGE 48

      Antibodies and proteomics 49

      Detection of fusion proteins 49

      Labeling and detection of proteins 50

      Fluorescent labeling of proteins in living cells 50

      Combination of microspheres with fluorescence 50

      Self-labeling protein tags 51

      Analysis of peptides 51

      C-terminal peptide analysis 52

      Differential Peptide Display 52

      Peptide analyses using NanoLC-MS 53

      Protein sequencing 53

      Real-time PCR for protein quantification 54

      Quantitative proteomics 54

      MS-based quantitative proteomics 54

      MS and cryo-electron tomography 55

      Functional proteomics: technologies for studying protein function 55

      Functional genomics by mass spectrometry 55

      RNA-Protein fusions 55

      Designed repeat proteins 56

      Application of nanbiotechnology to proteomics 56

      Nanoproteomics 56

      Protein nanocrystallography 57

      Single-molecule mass spectrometry using a nanopore 57

      Nanoelectrospray ionization 57

      Nanoparticle barcodes 58

      Biobarcode assay for proteins 58

      Nanobiotechnology for discovery of protein biomarkers in the blood 60

      Nanoscale protein analysis 60

      Nanoscale mechanism for protein engineering 61

      Nanotube electronic biosensor 61

      Nanotube-vesicle networks for study of membrane proteins 62

      Nanowire transistor for the detection of protein-protein interactions 62

      Qdot-nanocrystals 62

      Resonance Light Scattering technology 63

      Study of single membrane proteins at subnanometer resolution 63

      Protein expression profiling 63

      Cell-based protein assays 64

      Living cell-based assays for protein function 65

      Companies developing cell-based protein assays 65

      Protein function studies 66

      Transcriptionally Active PCR 66

      Protein-protein interactions 66

      Yeast two-hybrid system 68

      Membrane one-hybrid method 69

      Protein affinity chromatography 69

      Phage display 69

      Fluorescence Resonance Energy Transfer 70

      Bioluminescence Resonance Energy Transfer 70

      Detection Enhanced Ubiquitin Split Protein Sensor technology 70

      Protein-fragment complementation system 71

      In vivo study of protein-protein interactions 71

      Computational prediction of interactions 72

      Interactome 72

      Protein-protein interactions and drug discovery 73

      Companies with technologies for protein-protein interaction studies 73

      Protein-DNA interaction 74

      Determination of protein structure 74

      X-Ray crystallography 75

      Nuclear magnetic resonance 76

      Electron spin resonance 76

      Prediction of protein structure 76

      Protein tomography 77

      X-ray scattering-based method for determining the structure of proteins 78

      Prediction of protein function 78

      Three-dimensional proteomics for determination of function 79

      An algorithm for genome-wide prediction of protein function 79

      Monitoring protein function by expression profiling 79

      Isotope-coded affinity tag peptide labeling 80

      Differential Proteomic Panning 80

      Cell map proteomics 81

      Topological proteomics 81

      Organelle or subcellular proteomics 82

      Nucleolar proteomics 82

      Glycoproteomic technologies 83

      High-sensitivity glycoprotein analysis 83

      Fluorescent in vivo imaging of glycoproteins 83

      Integrated approaches for protein characterization 83

      Imaging mass spectrometry 84

      IMS technologies 84

      Applications of IMS 84

      The protein microscope 85

      Automation and robotics in proteomics 85

      Laser capture microdissection 86

      Microdissection techniques used for proteomics 86

      Uses of LCM in combination with proteomic technologies 86

      Concluding remarks about applications of proteomic technologies 87

      Precision proteomics 87

      3. Protein biochip technology 89

      Introduction 89

      Types of protein biochips 90

      ProteinChip 90

      Applications and advantages of ProteinChip 91

      ProteinChip Biomarker System 91

      Matrix-free ProteinChip Array 92

      Aptamer-based protein biochip 92

      Fluorescence planar wave guide technology-based protein biochips 93

      Lab-on-a-chip for protein analysis 93

      Microfluidic biochips for proteomics 94

      Protein biochips for high-throughput expression 95

      Nucleic Acid-Programmable Protein Array 95

      High-density protein microarrays 95

      HPLC-Chip for protein identification 95

      Antibody microarrays 96

      Integration of protein array and image analysis 96

      Tissue microarray technology for proteomics 96

      Protein biochips in molecular diagnostics 97

      A force-based protein biochip 98

      L1 chip and lipid immobilization 98

      Multiplexed Protein Profiling on Microarrays 98

      Live cell microarrays 99

      ProteinArray Workstation 99

      Proteome arrays 100

      The Yeast ProtoArray 100

      ProtoArrayÔ Human Protein Microarray 100

      TRINECTIN proteome chip 101

      Peptide arrays 101

      Surface plasmon resonance technology 102

      Biacore's SPR 102

      FLEX CHIP 102

      Combination of surface plasmon resonance and MALDI-TOF 103

      Protein chips/microarrays using nanotechnology 103

      Nanoparticle protein chip 103

      Protein nanobiochip 103

      Protein nanoarrays 104

      Self-assembling protein nanoarrays 104

      Companies involved in protein biochip/microarray technology 105

      4. Bioinformatics in Relation to Proteomics 109

      Introduction 109

      Bioinformatic tools for proteomics 109

      Testing of SELDI-TOF MS Proteomic Data 109

      BioImagine's ProteinMine 110

      Bioinformatics for pharmaceutical applications of proteomics 110

      In silico search of drug targets by Biopendium 110

      Compugen's LEADS 111

      DrugScore 111

      Proteochemometric modeling 111

      Integration of genomic and proteomic data 112

      Proteomic databases: creation and analysis 113

      Introduction 113

      Proteomic databases 113

      GenProtEC 114

      Human Protein Atlas 114

      Human Proteomics Initiative 115

      International Protein Index 116

      Proteome maps 116

      Protein Structure Initiative - Structural Genomics Knowledgebase 116

      Protein Warehouse Database 116

      Protein Data Bank 117

      Universal Protein Resource 117

      Protein interaction databases 117

      Biomolecular Interaction Network Database 118

      ENCODE 118

      Functional Genomics Consortium 119

      Human Proteinpedia 119

      ProteinCenter 119

      Databases of the National Center for Biotechnology Information 120

      Bioinformatics for protein identification 120

      Application of bioinformatics in functional proteomics 120

      Use of bioinformatics in protein sequencing 121

      Bottom-up protein sequencing 121

      Top-down protein sequencing 122

      Protein structural database approach to drug design 122

      Bioinformatics for high-throughput proteomics 123

      Companies with bioinformatic tools for proteomics 124

      5. Research in Proteomics 125

      Introduction 125

      Applications of proteomics in biological research 125

      Identification of novel human genes by comparative proteomics 125

      Study of relationship between genes and proteins 126

      Characterization of histone codes 126

      Structural genomics or structural proteomics 127

      Protein Structure Factory 128

      Protein Structure Initiative 128

      Studies on protein structure at Argonne National Laboratory 129

      Structural Genomics Consortium 129

      Protein knockout 130

      Antisense approach and proteomics 130

      RNAi and protein knockout 130

      Total knockout of cellular proteins 130

      Ribozymes and proteomics 131

      Single molecule proteomics 131

      Single-molecule photon stamping spectroscopy 131

      Single nucleotide polymorphism determination by TOF-MS 132

      Application of proteomic technologies in systems biology 132

      Signaling pathways and proteomics 132

      Kinomics 133

      Combinatorial RNAi for quantitative protein network analysis 133

      Proteomics in neuroscience research 133

      Stem cell proteomics 134

      hESC phosphoproteome 134

      Proteomic studies of mesenchymal stem cells 135

      Proteomics of neural stem cells 135

      Proteome Biology of Stem Cells Initiative 136

      Proteomic analysis of the cell cycle 137

      Nitric oxide and proteomics 137

      A proteomic method for identification of cysteine S-nitrosylation sites 137

      Study of the nitroproteome 137

      Study of the phosphoproteome 138

      Study of the mitochondrial proteome 138

      Proteomic technologies for study of mitochondrial proteomics 139

      Cryptome 139

      Study of protein transport in health and disease 139

      Proteomics research in the academic sector 140

      Vanderbilt University's Center for Proteomics and Drug Actions 142

      ProteomeBinders initiative 142

      6. Pharmaceutical Applications of Proteomics 143

      Introduction 143

      Current drug discovery process and its limitations 143

      Role of omics in drug discovery 144

      Genomics-based drug discovery 144

      Metabolomics technologies for drug discovery 145

      Role of metabonomics in drug discovery 145

      Basis of proteomics approach to drug discovery 146

      Proteins and drug action 146

      Transcription-aided drug design 147

      Role of proteomic technologies in drug discovery 147

      Liquid chromatography-based drug discovery 148

      Capture compound mass spectrometry 149

      Protein-expression mapping by 2DGE 149

      Role of MALDI mass spectrometry in drug discovery 149

      Tissue imaging mass spectrometry 149

      Companies using MALDI for drug discovery 151

      Oxford Genome Anatomy Project 151

      Proteins as drug targets 152

      Ligands to capture the purine binding proteome 152

      Chemical probes to interrogate key protein families for drug discovery 152

      Global proteomics for pharmacodynamics 153

      CellCarta® proteomics platform 153

      ZeptoMARKÔ protein profiling system 154

      Role of proteomics in targeting disease pathways 154

      Identification of protein kinases as drug targets 154

      Mechanisms of action of kinase inhibitors 155

      G-protein coupled receptors as drug targets 155

      Methods of study of GPCRs 156

      Cell-based assays for GPCR 156

      Companies involved in GPCR-based drug discovery 157

      GPCR localization database 158

      Matrix metalloproteases as drug targets 158

      PDZ proteins as drug targets 159

      Proteasome as drug target 159

      Serine hydrolases as drug targets 160

      Targeting mTOR signaling pathway 160

      Targeting caspase-8 for anticancer therapeutics 161

      Bioinformatic analysis of proteomics data for drug discovery 162

      Drug design based on structural proteomics 162

      Protein crystallography for determining 3D structure of proteins 162

      Automated 3D protein modeling 163

      Drug targeting of flexible dynamic proteins 163

      Companies involved in structure-based drug-design 163

      Integration of genomics and proteomics for drug discovery 164

      Ligand-receptor binding 165

      Role of proteomics in study of ligand-receptor binding 165

      Aptamer protein binding 166

      Systematic Evolution of Ligands by Exponential Enrichment 166

      Aptamers and high-throughput screening 166

      Nucleic Acid Biotools 167

      Aptamer beacons 167

      Peptide aptamers 168

      Riboreporters for drug discovery 168

      Target identification and validation 168

      Application of mass spectrometry for target identification 169

      Gene knockout and gene suppression for validating protein targets 169

      Laser-mediated protein knockout for target validation 169

      Integrated proteomics for drug discovery 170

      High-throughput proteomics 170

      Companies involved in high-throughput proteomics 171

      Drug discovery through protein-protein interaction studies 171

      Protein-protein interaction as basis for drug target identification 172

      Protein-PCNA interaction as basis for drug design 172

      Two-hybrid protein interaction technology for target identification 173

      Biosensors for detection of small molecule-protein interactions 173

      Protein-protein interaction maps 174

      ProNet (Myriad Genetics) 174

      Hybrigenics' maps of protein-protein interactions 174

      CellZome's functional map of protein-protein interactions 175

      Mapping of protein-protein interactions by mass spectrometry 175

      Protein interaction map of Drosophila melanogaster 176

      Protein-interaction map of Wellcome Trust Sanger Institute 176

      Protein-protein interactions as targets for therapeutic intervention 176

      Inhibition of protein-protein interactions by peptide aptamers 177

      Selective disruption of proteins by small molecules 177

      Post-genomic combinatorial biology approach 177

      Differential proteomics 178

      Shotgun proteomics 178

      Chemogenomics/chemoproteomics for drug discovery 179

      Chemoproteomics-based drug discovery 180

      Companies involved in chemogenomics/chemoproteomics 181

      Activity-based proteomics 182

      Locus Discovery technology 182

      Automated ligand identification system 183

      Expression proteomics: protein level quantification 183

      Role of phage antibody libraries in target discovery 184

      Analysis of posttranslational modification of proteins by MS 184

      Phosphoproteomics for drug discovery 185

      Application of glycoproteomics for drug discovery 185

      Role of carbohydrates in proteomics 185

      Challenges of glycoproteomics 186

      Companies involved in glycoproteomics 186

      Role of protein microarrays/ biochips for drug discovery 187

      Protein microarrays vs DNA microarrays for high-throughput screening 187

      BIA-MS biochip for protein-protein interactions 187

      ProteinChip with Surface Enhanced Neat Desorption 188

      Protein-domains microarrays 188

      Some limitations of protein biochips 188

      Concluding remarks about role of proteomics in drug discovery 189

      RNA versus protein profiling as guide to drug development 189

      RNA as drug target 189

      Combination of RNA and protein profiling 190

      RNA binding proteins 191

      Toxicoproteomics 191

      Hepatotoxicity 191

      Nephrotoxicity 192

      Cardiotoxicity 192

      Neurotoxicity 193

      Protein/peptide therapeutics 193

      Peptide-based drugs 193

      Phylomer® peptides 194

      Cryptein-based therapeutics 194

      Synthetic proteins and peptides as pharmaceuticals 195

      Genetic immunization and proteomics 195

      Proteomics and gene therapy 196

      Role of proteomics in clinical drug development 196

      Pharmacoproteomics 196

      Role of proteomics in clinical drug safety 197

      7. Application of Proteomics in Human Healthcare 199

      Introduction 199

      Clinical proteomics 200

      Definition and standards 200

      Vermillion's Clinical Proteomics Program 200

      Pathophysiology of human diseases 201

      Diseases due to misfolding of proteins 201

      Mechanism of protein folding 202

      Nanoproteomics for study of misfolded proteins 203

      Therapies for protein misfolding 203

      Intermediate filament proteins 204

      Significance of mitochondrial proteome in human disease 205

      Proteome of Saccharomyces cerevisiae mitochondria 205

      Rat mitochondrial proteome 205

      Proteomic approaches to biomarker identification 206

      The ideal biomarker 206

      Proteomic technologies for biomarker discovery 206

      MALDI mass spectrometry for biomarker discovery 207

      BAMFÔ Technology 207

      Protein biochips/microarrays and biomarkers 208

      Antibody-based biomarker discovery 208

      Tumor-specific serum peptidome patterns 208

      Search for protein biomarkers in body fluids 209

      Challenges and strategies for discovey of protein biomarkers in plasma 209

      3-D structure of CD38 as a biomarker 210

      BD™ Free Flow Electrophoresis System 210

      Isotope tags for relative and absolute quantification 211

      N-terminal peptide isolation from human plasma 211

      Plasma protein microparticles as biomarkers 211

      Proteome partitioning 212

      SISCAPA method for quantitating proteins and peptides in plasma 212

      Stable isotope tagging methods 212

      Technology to measure both the identity and size of the biomarker 213

      Biomarkers in the urinary proteome 213

      Application of proteomics in molecular diagnosis 214

      Proximity ligation assay 215

      Protein patterns 215

      Proteomic tests on body fluids 215

      Cyclical amplification of proteins 217

      Applications of proteomics in infections 217

      Mass spectrometry for microbial identification 217

      Role of proteomics in virology 218

      Study of interaction of proteins with viruses 218

      Role of proteomics in bacteriology 218

      Epidemiology of bacterial infections 219

      Proteomic approach to bacterial pathogenesis 219

      Vaccines for bacterial infections 219

      Protein profiles associated with bacterial drug resistance 220

      Analyses of the parasite proteome 220

      Application of proteomics in cystic fibrosis 221

      Proteomics of cardiovascular diseases 221

      Pathomechanism of cardiovascular diseases 221

      Study of cardiac mitochondrial proteome in myocardial ischemia 221

      Cardiac protein databases 222

      Proteomics of dilated cardiomyopathy and heart failure 222

      Proteomic biomarkers of cardiovascular diseases 223

      Role of proteomics in cardioprotection 223

      Role of proteomics in heart transplantation 223

      Future of application of proteomics in cardiology 224

      Proteomic technologies for research in pulmonary disorders 224

      Application of proteomics in renal disorders 225

      Diagnosis of renal disorders 225

      Proteomic biomarkers of acute kidney injury 226

      Cystatin C as biomarker of glomerular filtration rate 226

      Protein biomarkers of nephritis 226

      Proteomics and kidney stones 227

      Proteomics of eye disorders 227

      Proteomics of cataract 227

      Proteomics of diabetic retinopathy 228

      Retinal dystrophies 228

      Use of proteomics in inner ear disorders 229

      Use of proteomics in aging research 229

      Removal of altered cellular proteins in aging 230

      Alteration of glycoproteins during aging 230

      Proteomics and nutrition 230

      8. Oncoproteomics 231

      Introduction 231

      Proteomic technologies for study of cancer 232

      Application of CellCarta technology for oncology 232

      Accentuation of differentially expressed proteins using phage technology 232

      Identification of oncogenic tyrosine kinases using phosphoproteomics 232

      Single-cell protein expression analysis by microfluidic techniques 233

      Dynamic cell proteomics in response to a drug 233

      Desorption electrospray ionization for cancer diagnosis 233

      Proteomic analysis of cancer cell mitochondria 234

      Mass spectrometry for identification of oncogenic chimeric proteins 234

      Id proteins as targets for cancer therapy 235

      Proteomic study of p53 235

      Human Tumor Gene Index 235

      Integration of cancer genomics and proteomics 236

      Laser capture microdissection technology and cancer proteomics 236

      Cancer tissue proteomics 237

      Use of proteomics in cancers of various organ systems 237

      Proteomics of brain tumors 237

      Proteomics of breast cancer 238

      Proteomics of colorectal cancer 240

      Proteomics of esophageal cancer 240

      Proteomics of hepatic cancer 240

      Proteomics of leukemia 241

      Proteomics of lung cancer 242

      Proteomics of pancreatic cancer 242

      Proteomics of prostate cancer 242

      Diagnostic use of cancer biomarkers 243

      Proteomic technologies for tumor biomarkers 244

      Nuclear matrix proteins (NMPs) 244

      Antiannexins as tumor markers in lung cancer 245

      NCI's Network of Clinical Proteomic Technology Centers 245

      Proteomics and tumor immunology 246

      Proteomics and study of tumor invasiveness 247

      Anticancer drug discovery and development 247

      Kinase-targeted drug discovery in oncology 247

      Anticancer drug targeting: functional proteomics screen of proteases 248

      Small molecule inhibitors of cancer-related proteins 248

      Role of proteomics in studying drug resistance in cancer 249

      Future prospects of oncoproteomics 249

      Companies involved in application of proteomics to oncology 249

      9. Neuroproteomics 251

      Introduction 251

      Proteomics of prion diseases 251

      Transmissible spongiform encephalopathies 252

      Creutzfeld-Jakob disease 252

      Bovine spongiform encephalopathy 253

      Variant Creutzfeldt-Jakob disease 253

      Protein misfolding and neurodegenerative disorders 253

      Ion channel link for protein-misfolding disease 253

      Detection of misfolded proteins 254

      Neurodegenerative disorders with protein abnormalities 254

      Alzheimer disease 256

      Common denominators of Alzheimer and prion diseases 256

      Parkinson disease 257

      Amyotrophic lateral sclerosis 257

      Proteomics and glutamate repeat disorders 258

      Proteomics and Huntington's disease 258

      Proteomics and demyelinating diseases 259

      Proteomics of neurogenetic disorders 259

      Fabry disease 259

      GM1 gangliosidosis 260

      Quantitative proteomics and familial hemiplegic migraine 260

      Proteomics of spinal muscular atrophy 261

      Proteomics of CNS trauma 261

      Proteomics of traumatic brain injury 261

      Chronic traumatic encephalopathy and ALS 262

      Proteomics of CNS aging 262

      Protein aggregation as a bimarker of aging 262

      Neuroproteomics of psychiatric disorders 263

      Neuroproteomic of cocaine addiction 263

      Neurodiagnostics based on proteomics 264

      Disease-specific proteins in the cerebrospinal fluid 264

      Tau proteins 265

      CNS tissue proteomics 265

      Diagnosis of CNS disorders by examination of proteins in urine 267

      Diagnosis of CNS disorders by examination of proteins in the blood 267

      Serum pNF-H as biomarker of CNS damage 268

      Proteomics of BBB 268

      Future prospects of neuroproteomics in neurology 269

      HUPO's Pilot Brain Proteome Project 270

      10. Commercial Aspects of Proteomics 271

      Introduction 271

      Potential markets for proteomic technologies 271

      Geographical distribution of proteomics technologies markets 272

      Markets for protein separation technologies 272

      Markets for 2D gel electrophoresis 273

      Trends in protein separation technolgies and effect on market 273

      Protein biochip markets 273

      Mass spectrometry markets 274

      Markets for MALDI for drug discovery 274

      Markets for nuclear magnetic resonance spectroscopy 274

      Market for structure-based drug design 275

      Bioinformatics markets for proteomics 275

      Markets for protein biomarkers 275

      Markets for cell-based protein assays 275

      Business and strategic considerations 276

      Cost of protein structure determination 276

      Opinion surveys of the scientist consumers of proteomic technologies 276

      Opinions on mass spectrometry 276

      Opinions on bioinformatics and proteomic databases 276

      Systems for in vivo study of protein-protein interactions 277

      Perceptions of the value of protein biochip/microfluidic systems 277

      Small versus big companies 277

      Expansion in proteomics according to area of application 277

      Growth trends in cell-based protein assay market 278

      Challenges for development of cell-based protein assays 278

      Future trends and prospects of cell-based protein assays 278

      Strategic collaborations 279

      Analysis of proteomics collaborations according to types of companies 279

      Types of proteomic collaborations 280

      Proteomics collaborations according to application areas 280

      Analysis of proteomics collaborations: types of technologies 280

      Collaborations based on protein biochip technology 281

      Concluding remarks about proteomic collaborations 281

      Proteomic patents 282

      Market drivers in proteomics 282

      Needs of the pharmaceutical industry 282

      Need for outsourcing proteomic technologies 283

      Funding of proteomic companies and research 283

      Technical advances in proteomics 283

      Changing trends in healthcare in future 284

      Challenges facing proteomics 284

      Magnitude and complexity of the task 284

      Technical challenges 284

      Limitations of proteomics 285

      Limitations of 2DGE 285

      Limitations of mass spectrometry techniques 285

      Complexity of the pharmaceutical proteomics 285

      Unmet needs in proteomics 286

      11. Future of Proteomics 287

      Genomics to proteomics 287

      Faster technologies 287

      FLEXGene repository 287

      Need for new proteomic technologies 288

      Emerging proteomic technologies 289

      Detection of alternative protein isoforms 289

      Direct protein identification in large genomes by mass spectrometry 289

      Proteome identification kits with stacked membranes 289

      Vacuum deposition interface 290

      In vitro protein biosynthesis 290

      Proteome mining with adenosine triphosphate 290

      Proteome-scale purification of human proteins from bacteria 290

      Proteostasis network 291

      Cytoproteomics 291

      Subcellular proteomics 291

      Individual cell proteomics 292

      Live cell proteomics 292

      Fluorescent proteins for live-cell imaging 293

      Membrane proteomics 293

      Identification of membrane proteins by tandem MS of protein ions 293

      Solid state NMR for study of nanocrystalline membrane proteins 294

      Multiplex proteomics 294

      High-throughput for proteomics 294

      Future directions for protein biochip application 295

      Bioinformatics for proteomics 295

      High-Throughput Crystallography Consortium 295

      Study of protein folding by IBM's Blue Gene 296

      Study of proteins by atomic force microscopy 296

      Population proteomics 296

      Comparative proteome analysis 297

      Human Proteome Organization 297

      Human Salivary Proteome 298

      Academic-commercial collaborations in proteomics 298

      Indiana Centers for Applied Protein Sciences 298

      Role of proteomics in the healthcare of the future 299

      Proteomics and molecular medicine 299

      Proteodiagnostics 299

      Proteomics and personalized medicine 300

      Targeting the ubiquitin pathway for personalized therapy of cancer 300

      Protein patterns and personalized medicine 300

      Personalizing interferon therapy of hepatitis C virus 302

      Protein biochips and personalized medicine 302

      Combination of diagnostics and therapeutics 303

      Future prospects 303

      12. References 305

      Tables

      Table 1?1: Landmarks in the evolution of proteomics 17

      Table 1?2: Comparison of DNA and protein 26

      Table 1?3: Comparison of mRNA and protein 26

      Table 1?4: Methods of analysis at various levels of functional genomics 32

      Table 2?1: Proteomics technologies 35

      Table 2?2: Protein separation technologies of selected companies 40

      Table 2?3: Companies supplying mass spectrometry instruments 42

      Table 2?4: Companies involved in cell-based protein assays 65

      Table 2?5: Methods used for the study of protein-protein interactions 67

      Table 2?6: A selection of companies involved in protein-protein interaction studies 73

      Table 2?7: Proteomic technologies used with laser capture microdissection 87

      Table 3?1: Applications of protein biochip technology 89

      Table 3?2: Selected companies involved in protein biochip/microarray technology 105

      Table 4?1: Proteomic databases and other Internet sources of proteomics information 113

      Table 4?2: Protein interaction databases available on the Internet 118

      Table 4?3: Bioinformatic tools for proteomics from academic sources 123

      Table 4?4: Selected companies involved in bioinformatics for proteomics 124

      Table 5?1: Applications of proteomics in basic biological research 125

      Table 5?2: A sampling of proteomics research projects in academic institutions 140

      Table 6?1: Pharmaceutical applications of proteomics 143

      Table 6?2: Selected companies relevant to MALDI-MS for drug discovery 151

      Table 6?3: Selected companies involved in GPCR-based drug discovery 157

      Table 6?4: Companies involved in drug design based on structural proteomics 164

      Table 6?5: Proteomic companies with high-throughput protein expression technologies 171

      Table 6?6: Selected companies involved in chemogenomics/chemoproteomics 181

      Table 6?7: Companies involved in glycoproteomic technologies 186

      Table 7?1: Applications of proteomics in human healthcare 199

      Table 7?2: Eye disorders and proteomic approaches 227

      Table 8?1: Companies involved in applications of proteomics to oncology 250

      Table 9?1: Neurodegenerative diseases with underlying protein abnormality 254

      Table 9?2: Disease-specific proteins in the cerebrospinal fluid of patients 264

      Table 10?1: Potential markets for proteomic technologies 2011-2021 271

      Table 10?2: Geographical distribution of markets for proteomic technologies 2011-2021 272

      Table 10?3: 2011 revenues of major companies from protein separation technologies 272

      Table 11?1: Role of proteomics in personalizing strategies for cancer therapy 300

      Figures

      Figure 1?1: A schematic miRNA pathway 20

      Figure 1?2: Relationship of DNA, RNA and protein in the cell 27

      Figure 1?3: Protein production pathway from gene expression to functional protein with controls. 29

      Figure 1?4: Parallels between functional genomics and proteomics 30

      Figure 2?1: Proteomics: flow from sample preparation to characterization 36

      Figure 2?2: The central role of spectrometry in proteomics 42

      Figure 2?3: Electrospray ionization (ESI) 43

      Figure 2?4: Matrix-Assisted Laser Desorption/Ionization (MALDI) 44

      Figure 2?5: Scheme of bio-bar-code assay 60

      Figure 2?6: A diagrammatic presentation of yeast two-hybrid system 68

      Figure 3?1: ProteinChip System 91

      Figure 3?2: Surface plasma resonance (SPR) 102

      Figure 4?1: Role of bioinformatics in integrating genomic/proteomic-based drug discovery 112

      Figure 4?2: Bottom-up and top-down approaches for protein sequencing 121

      Figure 6?1: Drug discovery process 144

      Figure 6?2: Regulatory changes induced by drugs and implemented at the proteins level. 147

      Figure 6?3: Relation of proteome to genome, diseases and drugs 148

      Figure 6?4: The mTOR pathways 161

      Figure 6?5: Steps in shotgun proteomics 179

      Figure 6?6: Chemogenomic approach to drug discovery (3-Dimensional Pharmaceuticals) 180

      Figure 8?1: Relation of oncoproteomics to other technologies 231

      Figure 9?1: A scheme of proteomics applications in CNS drug discovery and development 270

      Figure 10?1: Types of companies involved in proteomics collaborations 279

      Figure 10?2: Types of collaborations: R &

      To order this report:

      Genomics Industry: Proteomics - Technologies, Markets and Companies

      More  Market Research Report

      Check our  Industry Analysis and Insights

      CONTACT:
      Nicolas Bombourg
      Reportlinker
      Email: nbo@reportlinker.com
      US: (805)652-2626
      Intl: +1 805-652-2626

      SOURCE Reportlinker

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.